ArticleBMC pharmacology & toxicology2026
Investigating the mechanisms by which bisphenol A affects osteoarthritis through a novel network toxicology framework and experimental validation.
Article in BMC pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundIn this study, we adopted network toxicology approaches to explore the potential risk effects of bisphenol A (BPA) on osteoarthritis (OA) processes.
methodsTargets related to BPA were obtained from the ChEMBL, Swiss Target Prediction, and STITCH databases, and OA-related targets were obtained from the GeneCards, DisGeNET, and OMIM databases; using the obtained information, we identified common targets. Then, the core targets were determined using the STRING database and the Cytoscape software, and functional enrichment analysis was subsequently conducted to elucidate the potential mechanisms. Moreover, a comprehensive validation of the core targets was conducted through molecular docking and dynamics simulations. Moreover, clinical samples were collected for experimental validation.
resultsA total of 88 overlapping targets were identified, and six core targets (SRC, ESR1, EGFR, PTGS2, PPARG, and HSP90AA1) were further screened. The results of the enrichment analysis revealed that the main pathways through which BPA affects OA involve key signaling cascades, including the estrogen signaling pathway, the thyroid hormone signaling pathway, and the ErbB signaling pathway. The results of molecular docking and dynamic simulations indicated that there are stable binding interactions between BPA and the core targets. The results of the RT-qPCR and IHC assays revealed significant differences in the core targets between the OA group and the normal group.
conclusionsThis study links the environmental toxin BPA with OA, systematically describing potential core targets and pathways. These findings emphasize the importance of reducing BPA exposure in public health, providing new insights for the formulation of subsequent environmental policies.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.